Remove Provider Remove Relationship Remove Telemedicine Remove Webinar
article thumbnail

CONTINUED AGAIN: DEA Announces A Second Extension of its “Temporary Rule” Addressing Telemedicine Flexibilities After the End of the COVID-19 Pandemic Emergency

FDA Law Blog

Palmer — On Friday, October 6, 2023, DEA announced a second extension of telemedicine flexibilities concerning the prescribing of controlled substances, which were originally set to expire after the end of the COVID-19 pandemic emergency. By Karla L. DEA received a whopping 38,000 (!)

article thumbnail

Behind the stethoscope: A conversation with Dr. Osman Saleem

Sound Physicians

In the back of my mind, I held the image of a once-prestigious Sound hospitalist program and the positive relationship once held with hospital administration. In the back of my mind, I held the image of a once-prestigious Sound hospitalist program and the positive relationship once held with hospital administration.

article thumbnail

Telemedicine and the Prescribing of Controlled Substances After the End of The Covid-19 Pandemic Emergency: DEA Announces Two Significant Proposed Rules: Read the Summary Below, But Learn All the Details and More at HPM’s Webinar on March 23, 2023 (Details Forthcoming….)

FDA Law Blog

Palmer — The 2008 Ryan Haight Online Pharmacy Consumer Protection Act placed strict limits on online prescribing or the use of telemedicine encounters to prescribe controlled substances. The Act also established new definitions for “Internet,” “online pharmacy,” “practice of telemedicine,” among others. By Karla L. 21 U.S.C. §